News
British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...
GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...
GSK has been found guilty of bringing discredit on the pharma industry after a complainan | GSK has been found guilty of ...
Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...
GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in ...
3d
Zacks Investment Research on MSNGSK's Pentavalent Meningococcal Jab Recommended for Use by ACIPGSK plc GSK announced that the U.S. Centers for Disease Control and Prevention’s (“CDC”) Advisory Committee on Immunization ...
GSK’s blood cancer drug Blenrep won regulatory approval in the U.K., marking the medicine’s return to the market after it was ...
3d
Pharmaceutical Technology on MSNACIP recommends GSK’s RSV vaccine for at-risk adults 50 to 59The recommendation builds on the committee’s June 2024 vote for the use of RSV vaccines for people aged 60 to 74 at high risk ...
6don MSN
A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE:GSK) Blenrep.
GSK (GSK) said it is “pleased” that the Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results